The effect and therapeutic compliance of adjuvant therapy in patients with cholangiocarcinoma after R0 resection: a retrospective study

The effect and therapeutic compliance of adjuvant therapy in patients with cholangiocarcinoma after R0 resection: a retrospective study

Background This study aimed to compare clinical outcomes between surveillance and adjuvant therapy (AT) groups after R0 resection for cholangiocarcinoma (CCA). Methods A total of 154 patients who underwent R0 resection for CCA at the Daegu Catholic University Medical Center between January 2010 and...

Full description

Bibliographic Details
Main Authors:	Han Taek Jeong, Joonkee Lee, Hyeong Ho Jo, Ho Gak Kim, Jimin Han
Format:	Article
Language:	English
Published:	Yeungnam University College of Medicine, Yeungnam University Institute Medical Science 2023-01-01
Series:	Journal of Yeungnam Medical Science
Subjects:	adjuvant chemotherapy biliary tract surgical procedures cholangiocarcinoma survival analysis watchful waiting
Online Access:	http://www.e-jyms.org/upload/pdf/jyms-2022-00213.pdf

Similar Items

Left hepatectomy for cholangiocarcinoma: case report and literature review
by: Antonio Luis de Vasconcelos Macedo, et al.
Published: (2003-03-01)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
by: Amram Kupietzky, et al.
Published: (2022-12-01)

Current Situation of Postoperative Adjuvant Chemoradiotherapy for Extrahepatic Cholangiocarcinoma
by: YANG Xiao, et al.
Published: (2023-01-01)

Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
by: Changhoon Yoo, et al.
Published: (2021-04-01)

Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification
by: Jun-Zhe Zhang, et al.
Published: (2023-08-01)

Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
by: Yueting Zhu, et al.
Published: (2023-09-01)

Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma
by: Mayur Parkhi, et al.
Published: (2023-11-01)

The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma
by: Andrea Palloni, et al.
Published: (2023-05-01)

The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma
by: Guergana Panayotova, et al.
Published: (2021-05-01)

Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection
by: Xiao-hui Li, et al.
Published: (2022-11-01)

Adjuvant treatment after resection of biliary-tract cancer: yes or no?
by: Eveline Boucher, et al.
Published: (2011-12-01)

The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection
by: Young Saing Kim, et al.
Published: (2017-01-01)

Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection
by: Xiao‐hui Li, et al.
Published: (2023-12-01)

The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis
by: Yoichi Miyata, et al.
Published: (2021-03-01)

Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement
by: Hossein Taghizadeh, et al.
Published: (2023-08-01)

A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis
by: Qi Li, et al.
Published: (2022-06-01)

Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
by: Christoph Roderburg, et al.
Published: (2021-06-01)

Vascular Resection in Perihilar Cholangiocarcinoma
by: Alejandro Serrablo, et al.
Published: (2021-10-01)

Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures
by: Alessandro Rizzo, et al.
Published: (2020-11-01)

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
by: Monica Niger, et al.
Published: (2024-04-01)

Long‐term outcomes of laparoscopic versus open liver resection for intrahepatic combined hepatocellular‐cholangiocarcinoma with propensity score matching
by: Seung Jae Lee, et al.
Published: (2022-07-01)

Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
by: Gennaro Gadaleta-Caldarola, et al.
Published: (2022-10-01)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
by: Oraianthi Fiste, et al.
Published: (2021-04-01)

Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date
by: Uson Junior PLS, et al.
Published: (2023-09-01)

Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report
by: Ryosuke Takayanagi, et al.
Published: (2017-11-01)

Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup
by: Zhao J, et al.
Published: (2020-12-01)

Successful surgical management of an extrahepatic biliary cystadenocarcinoma
by: Márcio Lobo Guimarães, et al.
Published: (2011-10-01)

Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy
by: Christian Möhring, et al.
Published: (2023-08-01)

Aspirin use is associated with a reduced risk of cholangiocarcinoma: a systematic review and meta-analysis
by: Xiong JP, et al.
Published: (2018-10-01)

Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience
by: Kentaro Iwaki, et al.
Published: (2024-03-01)

Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles
by: Eliza W. Beal, et al.
Published: (2020-12-01)

Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review
by: Alessandra Elvevi, et al.
Published: (2023-01-01)

Pathology of Cholangiocarcinomas
by: Nathalie Guedj
Published: (2022-12-01)

Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
by: Xiaobo Bo, et al.
Published: (2018-03-01)

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study
by: Alexander R. Siebenhüner, et al.
Published: (2018-01-01)

Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
by: Sandra Pavicevic, et al.
Published: (2022-02-01)

Clinical treatment of cholangiocarcinoma: an updated comprehensive review
by: Alessandra Elvevi, et al.
Published: (2022-09-01)

Presentation and Outcomes with First-Line Chemotherapy in Advanced Cholangiocarcinomas—A Relatively Rare Component of Biliary Tract Cancers in India
by: Prabhat G. Bhargava, et al.
Published: (2020-10-01)

A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)
by: Osamu Itano, et al.
Published: (2020-07-01)